Disease Activity and Increased Risk of Cardiovascular Death among Patients with Psoriatic Arthritis

Kristina Juneblad1,2, Solbritt Rantapää-Dahlqvist3,4, Gerd-Marie Alenius3,4

  • 1From the Department of Public Health and Clinical Medicine, and the Department of Rheumatology, University Hospital, Umeå, Sweden. kristina.juneblad@vll.se.

Insights

Patients with psoriatic arthritis (PsA) have a slightly increased risk of death from circulatory diseases. Higher disease activity and combined axial and peripheral involvement are linked to increased mortality in PsA patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Psoriatic arthritis (PsA) is associated with increased cardiovascular (CV) morbidity and mortality, though findings are inconsistent.
  • Understanding the specific mortality rates and causes of death in PsA patients is crucial for risk stratification and management.

Purpose of the Study:

  • To investigate the mortality rate, causes of death, and incidence of acute CV events in a cohort of PsA patients from northern Sweden.
  • To determine the association between disease activity and mortality in PsA.

Main Methods:

  • A cohort of 464 patients with established PsA was studied from 1995-2011.
  • Standardized mortality ratios (SMR) and standardized incidence ratios (SIR) for CV events were calculated by comparing PsA patients to the general population using Swedish national registers.
  • Disease activity index (DAI) and disease phenotype (peripheral vs. axial and peripheral) were analyzed for their association with mortality.

Main Results:

  • The SMR for death from circulatory diseases (ICD-10: I00-I99) was 1.64 (95% CI 1.02-2.52), indicating a significant increase compared to the general population.
  • Higher DAI was significantly associated with death (OR 1.99), as was the combination of axial and peripheral disease (OR 4.02).
  • The SIR for CV events (myocardial infarction or stroke) was 0.597, a significant decrease, but this was only observed in men.

Conclusions:

  • PsA patients exhibit a small but significant increase in mortality due to circulatory system diseases.
  • Disease activity and more aggressive disease phenotypes (axial and peripheral involvement) are associated with increased mortality in PsA patients.
  • The observed lower incidence of CV events in PsA patients warrants further investigation, particularly regarding sex differences.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
644
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
870
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
521
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
711